NCT07142005

Brief Summary

To find good information about medullary thyroid cancer that is easy to understand and reliable, so researchers aim to design some new educational materials to help.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
23mo left

Started Aug 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Aug 2025Mar 2028

First Submitted

Initial submission to the registry

June 20, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

August 15, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 26, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2028

Expected
Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

June 20, 2025

Last Update Submit

March 31, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Questionnaires/Survey Measures

    Through study completion; an average of 1 year

Interventions

* Questionnaires/Survey Measures * Qualitative Instruments

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

MD Anderson Cancer Center

You may qualify if:

  • Provision of signed and dated informed consent form
  • Males and females; Age: ≥18 years old
  • Identified ethnicity as "Hispanic" or "Latino/Latina"
  • Ability to read, write, and speak Spanish
  • Those who are pregnant are eligible to participate
  • Have or will face this decision, including: a. Participant/survivor - who has medullary thyroid carcinoma, as determined by a clinician or documented in Multi-Institutional Medullary Thyroid Cancer Collaborative Registry; b. Caregiver/family member - of Participant/survivor who has medullary thyroid carcinoma, as nominated by the Participant/survivor

You may not qualify if:

  • Those \< age 18
  • Ethnic identity as non-Hispanic or non-Latino/a individual
  • Individuals with cognitive or psychological impairment (e.g., depression, anxiety, severe mental illness as documented in the registry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MD Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Carcinoma, Medullary

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Carcinoma, NeuroendocrineNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms, Ductal, Lobular, and MedullaryNeoplasms, Nerve Tissue

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Elizabeth Grubbs, MD

    eggrubbs@mdanderson.org

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elizabeth Grubbs, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2025

First Posted

August 26, 2025

Study Start

August 15, 2025

Primary Completion

March 31, 2026

Study Completion (Estimated)

March 31, 2028

Last Updated

April 2, 2026

Record last verified: 2026-03

Locations